What is Enovis's cash & equivalents?

Enovis (ENOV) reported cash & equivalents of $33.13M in Q1 2026.

How has Enovis's cash & equivalents changed year-over-year?

Enovis's cash & equivalents decreased by 13.9% year-over-year, from $38.46M to $33.13M.

What is the long-term trend for Enovis's cash & equivalents?

Over 5 years (2020 to 2025), Enovis's cash & equivalents has grown at a 37.4% compound annual growth rate (CAGR), from $7.42M to $36.39M.

What does cash & equivalents mean?

Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.

Enovis ENOV Cash & Equivalents

Cash & Equivalents at other companies

Johnson & JohnsonJNJ

$21.69B-43.6%

StrykerSYK

$2.88B+24.1%

Zimmer Biomet HoldingsZBH

$424.2M-69.4%

ESABESAB

$1B+245%

VericelVCEL

$109.3M+37.1%

Globus MedicalGMED

$560.95M+21.6%

Other financials

Income statement

See full

Revenue$589.2M+5.4%

Gross profit$365.5M+10.0%

Operating income$6.5M+114%

Net income-$8.8M+84.3%

EPS (diluted)-$0.15+84.7%

Balance sheet

See full

Total debt$1.4B-3.1%

Total equity$1.5B-43.6%

Total assets$3.8B-21.4%

Cash flow

See full

Operating cash flow$24.0M+1,601%

CapEx$52.8M+22.1%

Free cash flow-$28.9M+35.7%

Valuation

See full

Market cap$1.23B-28.4%

Enterprise value$2.55B-17.1%

P/S0.5×-0.3×

Profitability

See full

Gross margin60.5%+4.0pp

Operating margin-47%+18.6pp

Net margin-49.9%+24.1pp

FCF margin-3.1%-1.1pp

Returns & leverage

See full

Return on equity-55.5%-1,722pp

Debt / equity0.9×+0.4×

Current ratio2×-0.5×

Where this comes from

Reported directly by Enovis in its filing.

Tagged under the XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue.

The official record: Enovis’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Enovis's cash & equivalents.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Enovis's cash & equivalents?: Enovis (ENOV) reported cash & equivalents of $33.13M in Q1 2026.
How has Enovis's cash & equivalents changed year-over-year?: Enovis's cash & equivalents decreased by 13.9% year-over-year, from $38.46M to $33.13M.
What is the long-term trend for Enovis's cash & equivalents?: Over 5 years (2020 to 2025), Enovis's cash & equivalents has grown at a 37.4% compound annual growth rate (CAGR), from $7.42M to $36.39M.
What does cash & equivalents mean?: Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.